Skip to main content

Table 4 Demographics distribution of patients used in microbiome and DMBT1 change correlation (Fig. 8)

From: Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer

Variable

 

Up (n = 15)

Down (n = 5)

 

N or mean (std)

N or mean (std)

p value

Age

Years

57.1 (7.2)

59.2 (9.9)

0.62

Gender

Male

12

2

0.27

Female

3

3

 

Clinical stage

2

1

-

1.00

3

2

1

 

4

12

4

 

T stage

T1

2

1

0.67

T2

8

1

 

T3

2

2

 

T4

3

1

 

N stage

N0

1

2

0.17

N1

3

0

 

N2

11

3

 

Disease site

Larynx

1

1

0.25

Oral cavity

2

-

 

Oropharynx

12

3

 

Nasopharynx

0

1

 

Treatment

Chemotherapy

0

1

0.15

Surgery

3

-

 

Chemoradiotherapy

12

4

 

ACE comorbidities score

None

5

1

0.36

Mild

8

3

 

Moderate

2

-

 

Severe

0

1

 

BMI

Normal (15.5–24.9)

2

-

0.84

Overweight (25–29.9)

6

3

 

Obese (30 +)

7

2

 

HPV status

Negative

3

3

0.25

Positive

12

2

 

Drinker

Never

1

-

1.00

Current

13

4

 

Former (quit > 12 months)

1

1

 

Smoker (cigarettes)

Never

5

-

0.04

Current

7

1

 

Former (quit > 12 months)

3

4

Â